Search Results 641-650 of 17123 for treatment resistant depression

  1. A Study to Evaluate the Safety and Effectiveness of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients - Mayo Clinic

    A Study to Evaluate the Safety and Effectiveness of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients · Share · Facebook · Twitter.

  2. Unexplained weight loss When to see a doctor - Mayo Clinic

    Treatment-resistant depression · Tricyclic antidepressants · Tuberculosis · Tumor vs. cyst: What's the difference? Type 1 diabetes · Type 1 diabetes in children ...

  3. A Study of SAR442085 in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    The purpose of this study is to determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory ...

  4. Mayo Clinic Radio: Mental Illness / Exercise in Extreme Heat / Testosterone Therapy

    Examples of mental illness include depression, anxiety disorders, schizophrenia, eating disorders and addictive behaviors. On the next Mayo Clinic Radio ...

  5. Clinical trials - Oncology (Medical)

    PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer.

  6. A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Study PT-112-102, a multicenter, open-label dose-finding and pharmacokinetic study of PT-112 in patients with relapsed or refractory multiple myeloma. This is ...

  7. Metformin Effect on Brain Function in Insulin Resistant People aged 60+ - Mayo Clinic

    Other studies have shown a link between the drug Metformin (the most widely used medication to treat prediabetes and type 2 diabetes) and a reduction in the ...

  8. Clinical trials - Oncology (Medical)

    PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer.

  9. A Study to Evaluate APG2575 Combined with Novel Therapeutic Regimens To Treat Subjects with Relapsed or Refractory Multiple Myeloma and Immunoglobulin Light Chain Amyloidosis - Mayo Clinic

    A Study to Evaluate APG2575 Combined with Novel Therapeutic Regimens To Treat Subjects with Relapsed or Refractory Multiple Myeloma and Immunoglobulin Light ...

  10. A Study of Single Patient Investigational Drug CPI-613 for Use in Treatment-Refractory, Metastatic Prostate Cancer - Mayo Clinic

    Clinical Trials · A Study of Single Patient Investigational Drug CPI-613 for Use in Treatment-Refractory, Metastatic Prostate Cancer · More about research at Mayo ...